Description

Oxidative stress markers in ulcerative colitis patients receiving curcumin show reductions in malondialdehyde and improvements in glutathione peroxidase activity, reflecting curcumin's antioxidant properties.

Figure 28

Chart

Source Paper

The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.

Nutrients (2020)

PMID: 32751776

DOI: 10.3390/nu12082296

Cite This Figure

![Figure 28: Oxidative stress markers in ulcerative colitis patients receiving curcumin show reductions in malondialdehyde and improvements in glutathione peroxidase activity, reflecting curcumin's antioxidant properties.]()

> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)

<figure>
  <img src="" alt="Oxidative stress markers in ulcerative colitis patients receiving curcumin show reductions in malondialdehyde and improvements in glutathione peroxidase activity, reflecting curcumin's antioxidant properties." />
  <figcaption>Figure 28. Oxidative stress markers in ulcerative colitis patients receiving curcumin show reductions in malondialdehyde and improvements in glutathione peroxidase activity, reflecting curcumin's antioxidant properties.<br>  Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption>
</figure>

Related Evidence

Curcumin for Ulcerative Colitis (UC)

Grade B · 5 studies

Curcumin for Crohn's Disease

Grade C · 3 studies